Gabriel García Márquez was born in 1928 in the small town of Aracataca, situated in a tropical region of northern Colombia, between the mountains and the Caribbean Sea. He grew up with his maternal grandparent - his grandfather was a pensioned colonel from the civil war at the beginning of the century. He went to a Jesuit college and began to read law, but his studies were soon broken off for his work as a journalist. In 1954 he was sent to Rome* on an assignment for his newspaper, and since then he has mostly lived abroad - in Paris, New York, Barcelona and Mexico - in a more or less compulsory exile. Besides his large output of fiction he has written screenplays and has continued to work as a journalist. | @LINK | http://bit.ly/c9n0jw
This video clip and the link to this PowerPoint slide show have probably gone viral on the web because today it was sent to my by a special friend. The author, nobel prize poet Gabriel Garcia Marquez, has broadcast this as a type of farewell message as he goes into seclusion for treatment of lymphatic cancer (lymphoma). Although I share the diagnosis with successful treatment twice for the disease, the need for periodic total public isolation and, at other times, partial seclusion while dealing with immune system recovery is a reality to which I relate so well. However, what I haven’t done as well as the genius Gabriel is construct such a telling and compelling message to convey the sentiments of my heart.
ACOR▶ a large collection of cancer-related online email lists, which has delivered millions of email messages to subscribers across the globe. https://goo.gl/mjrQ77
An INTRANET is a private network accessible only to an organization's staff or members. Generally a wide range of information and services from the organization's internal IT systems are available that would not be available to the public from the Internet. By function, ACORis an INTRANETsite.
When a #Canswerist (aka cancer survivor or caregiver) looks to begin or extend research for their diagnosis (DX), the world wide web (or internet) is a logical starting points. Typically, such a search may lead to discovery on a range of INTRANETS.
Bone marrow transplants, aka stem cell transplants (SCT) offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. I know because I am one of the SCT success stories from the place known as City of Hope (COH).▶ COH performed its first bone marrow transplant in 1976. Since then, thousands of patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at COH.▶ Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood.▶ It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).▶ It is a medical procedure in the field of hematology, most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma, lymphoma (my DX) or …
▶ Gradually, but surely, we are now archiving MyJournal posts in our G+ collection. Follow us there.
▶ First day of the winter solstice arrived yesterday and that generally means no real change in the weather conditions for Southern California, but we have finally had a few days of partly-cloudy rain to initiate the official changing of the seasons▶ Unfortunately and personally, the last few months have been mostly marked with prolonged and unrelenting respiratory distress, officially diagnosed last Friday as acute bronchitis.
▶ A new cocktail of medicines have been prescribed: 1) Ibratropium Bromide nasal spray; 2) Prednisone, a steroid; and 3) Benzonatate, a cough suppressant. All of this followed my third IVIG in three months since September at City of Hope, as that last procedure generally lasts me for six months, but not at this time. Immune system issues remain and underlying challenge in my ninth year post DX with mantle cell lymphoma and eight years post the allogeneic stem ce…